Antitumor agents. 144. New gamma-lactone ring-modified arylamino etoposide analogs as inhibitors of human DNA topoisomerase II

J Med Chem. 1994 Jan 21;37(2):287-92. doi: 10.1021/jm00028a012.

Abstract

The trans-fused gamma-lactone ring of etoposide is readily epimerized to its cis epimer, which is biologically inactive, or is metabolized to the inactive ring-opened hydroxy acids. Modification of this gamma-lactone ring of 4 beta-(arylamino)-4'-O-demethyl-4-desoxypodophyllotoxin resulted in several compounds (15-16, 21-22, and 24) that should block this epimerization and the resulting biological deactivation. In a topoisomerase II inhibition assay, compounds 21, 22, and 24 showed comparable activity to etoposide. In a protein-linked DNA complex formation assay, compounds 21 and 22 were more active than etoposide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line
  • DNA / drug effects
  • Ethers / pharmacology
  • Etoposide / analogs & derivatives*
  • Etoposide / pharmacology
  • Humans
  • Lactones / chemistry*
  • Topoisomerase II Inhibitors*

Substances

  • Antineoplastic Agents
  • Ethers
  • Lactones
  • Topoisomerase II Inhibitors
  • Etoposide
  • DNA